Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia
Abstract The evaluation of the somatic hypermutation of the clonotypic immunoglobulin heavy variable gene has become essential in the therapeutic management in chronic lymphocytic leukemia patients. European Research Initiative on Chronic Lymphocytic Leukemia promotes good practices and standardized...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9fb8cdff84594f8c80b607a419cdaf59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9fb8cdff84594f8c80b607a419cdaf59 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9fb8cdff84594f8c80b607a419cdaf592021-12-02T15:29:03ZNanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia10.1038/s41598-021-97198-32045-2322https://doaj.org/article/9fb8cdff84594f8c80b607a419cdaf592021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97198-3https://doaj.org/toc/2045-2322Abstract The evaluation of the somatic hypermutation of the clonotypic immunoglobulin heavy variable gene has become essential in the therapeutic management in chronic lymphocytic leukemia patients. European Research Initiative on Chronic Lymphocytic Leukemia promotes good practices and standardized approaches to this assay but often they are labor-intensive, technically complex, with limited in scalability. The use of next-generation sequencing in this analysis has been widely tested, showing comparable accuracy and distinct advantages. However, the adoption of the next generation sequencing requires a high sample number (run batching) to be economically convenient, which could lead to a longer turnaround time. Here we present data from nanopore sequencing for the somatic hypermutation evaluation compared to the standard method. Our results show that nanopore sequencing is suitable for immunoglobulin heavy variable gene mutational analysis in terms of sensitivity, accuracy, simplicity of analysis and is less time-consuming. Moreover, our work showed that the development of an appropriate data analysis pipeline could lower the nanopore sequencing error rate attitude.Crescenzio Francesco MinerviniCosimo CumboImmacolata RedavidMaria Rosa ConservaPaola OrsiniAntonella ZagariaLuisa AnelliNicoletta CoccaroGiuseppina TotaLuciana ImperaElisa ParcianteFrancesco TarantiniAnnamaria GiordanoGiorgina SpecchiaPellegrino MustoFrancesco AlbanoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Crescenzio Francesco Minervini Cosimo Cumbo Immacolata Redavid Maria Rosa Conserva Paola Orsini Antonella Zagaria Luisa Anelli Nicoletta Coccaro Giuseppina Tota Luciana Impera Elisa Parciante Francesco Tarantini Annamaria Giordano Giorgina Specchia Pellegrino Musto Francesco Albano Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
description |
Abstract The evaluation of the somatic hypermutation of the clonotypic immunoglobulin heavy variable gene has become essential in the therapeutic management in chronic lymphocytic leukemia patients. European Research Initiative on Chronic Lymphocytic Leukemia promotes good practices and standardized approaches to this assay but often they are labor-intensive, technically complex, with limited in scalability. The use of next-generation sequencing in this analysis has been widely tested, showing comparable accuracy and distinct advantages. However, the adoption of the next generation sequencing requires a high sample number (run batching) to be economically convenient, which could lead to a longer turnaround time. Here we present data from nanopore sequencing for the somatic hypermutation evaluation compared to the standard method. Our results show that nanopore sequencing is suitable for immunoglobulin heavy variable gene mutational analysis in terms of sensitivity, accuracy, simplicity of analysis and is less time-consuming. Moreover, our work showed that the development of an appropriate data analysis pipeline could lower the nanopore sequencing error rate attitude. |
format |
article |
author |
Crescenzio Francesco Minervini Cosimo Cumbo Immacolata Redavid Maria Rosa Conserva Paola Orsini Antonella Zagaria Luisa Anelli Nicoletta Coccaro Giuseppina Tota Luciana Impera Elisa Parciante Francesco Tarantini Annamaria Giordano Giorgina Specchia Pellegrino Musto Francesco Albano |
author_facet |
Crescenzio Francesco Minervini Cosimo Cumbo Immacolata Redavid Maria Rosa Conserva Paola Orsini Antonella Zagaria Luisa Anelli Nicoletta Coccaro Giuseppina Tota Luciana Impera Elisa Parciante Francesco Tarantini Annamaria Giordano Giorgina Specchia Pellegrino Musto Francesco Albano |
author_sort |
Crescenzio Francesco Minervini |
title |
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
title_short |
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
title_full |
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
title_fullStr |
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
title_full_unstemmed |
Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
title_sort |
nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/9fb8cdff84594f8c80b607a419cdaf59 |
work_keys_str_mv |
AT crescenziofrancescominervini nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT cosimocumbo nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT immacolataredavid nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT mariarosaconserva nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT paolaorsini nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT antonellazagaria nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT luisaanelli nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT nicolettacoccaro nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT giuseppinatota nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT lucianaimpera nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT elisaparciante nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT francescotarantini nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT annamariagiordano nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT giorginaspecchia nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT pellegrinomusto nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia AT francescoalbano nanoporesequencingapproachforimmunoglobulingeneanalysisinchroniclymphocyticleukemia |
_version_ |
1718387158931210240 |